000 | 01295 a2200397 4500 | ||
---|---|---|---|
005 | 20250513160519.0 | ||
264 | 0 | _c19990119 | |
008 | 199901s 0 0 fre d | ||
022 | _a0369-8114 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGuibert, J | |
245 | 0 | 0 |
_a[Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg]. _h[electronic resource] |
260 |
_bPathologie-biologie _cOct 1998 |
||
300 |
_a656-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Infective Agents, Urinary _xpharmacology |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 |
_aEnterococcus faecalis _xdrug effects |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOfloxacin _xpharmacokinetics |
650 | 0 | 4 |
_aStaphylococcus _xdrug effects |
700 | 1 | _aKitzis, M D | |
700 | 1 | _aAcar, J F | |
773 | 0 |
_tPathologie-biologie _gvol. 46 _gno. 8 _gp. 656-60 |
|
999 |
_c9834362 _d9834362 |